A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.

Journal article

A "reverse pharmacology" approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-outcome study. The second step was a dose-escalating clinical trial that showed a dose-response phenomenon and helped select the safest and most efficacious dose. The third step was a randomized controlled trial to compare the phytomedicine to the standard first-line treatment. The last step was to identify active compounds which can be used as markers for standardization and quality control. This example of "reverse pharmacology" shows that a standardized phytomedicine can be developed faster and more cheaply than conventional drugs. Even if both approaches are not fully comparable, their efficiency in terms of public health and their complementarity should be thoroughly considered.

Authors: Willcox, M; Graz, B; Falquet, J; Diakite, C; Giani, S

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: BioMed Central
• Journal: Malaria Journal
• Volume: 10
• Issue: Suppl. 1
• Article number: S8
• Publication date: 2011-01-01
• DOI: 10.1186/1475-2875-10-s1-s8
• EISSN: 1475-2875
• ISSN: 1475-2875
• Language: English
• Keywords: Dose-Response Relationship, Drug; Humans; Mali; Drug Discovery; Plants, Medicinal; Plants; Pharmacology, Clinical; Malaria; Herbal Medicine; Plasmodium; Antimalarials